摘要
对慢性非癌性疼痛的治疗目前仍然缺乏理想的镇痛药物,急需开发基于疼痛机制的靶向新型镇痛药物。电压门控性钙通道(VGCC)的改变是疼痛发生的重要分子基础,本文针对N型、T型及α2δ亚基VGCC为作用靶点的新型镇痛药物的研究进展作一综述。
As the treatment o.f chronic noncancer pain lacks effective analgesics at present, it is necessary to develop new analgesics selectively acting on the specific targets. The changes of voltage-gated calcium channels are the important molecule base of pain. This review describes the advances in N-type, T-type and α2δ subgroup calcium channels to be the molecular targets for new analgesic drugs.
出处
《世界临床药物》
CAS
2010年第7期433-437,共5页
World Clinical Drug
基金
国家"重大新药创制"科技重大专项资助(项目编号2009ZX09301-007)
关键词
慢性疼痛
电压门控性钙通道
镇痛药物
chronic pain
voltage gated calcium channels
analgesic drug